History
Our Team
Research and Development
Dermatology and Aesthetics
Hematology
Hemoderivatives
Immunology and Transplantation
Nephrology
Neurology
Oncology
Over The Counter
All products
KIMATINIB
Imatinib Mesylate
NOXPRIN
Sodium Enoxaparine
SUPRIMUN
Micophenolate Mofetil
CAPECITABINE SANDOZ
Capecitabine
News
KIMATINIB LAUNCHING
Monday, July 27, 2009
Laboratorios Clausen SA announces the launch of Kimatinib (Imatinib Mesylate), produced at the plant in High Technology Clausen.
Launching of Interferon beta-1 a Clausen
Sunday, May 31, 2009
Laboratorios Clausen S.A announces the launching of Interferón beta-1a Clausen in prefilled syringes 6 and 12 MIU, indicated for the treatment of relapsing-remitting Multiple Sclerosis.
Eritrogen: the known formula of human recombinant erythropoietin by Clausen
Wednesday, April 19, 2006
Eritrogen, recombinant human erythropoietin manufactured by Clausen, is now available in prefilled syringe containing 10.000 UI in 1 ml of solution.
View all News >>
